NEXGEL, INC. Additional Paid in Capital
NEXGEL, INC. (NXGL) had Additional Paid in Capital of $30.50 million as of 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2026-08-17
- 2026-06-30: Additional Paid in Capital $30.50M.
- 2026-03-31: Additional Paid in Capital $25.91M.
- 2025-12-31: Additional Paid in Capital $25.45M.
- 2025-09-30: Additional Paid in Capital $25.20M.
| Period end | Additional Paid in Capital | Additional Paid in Capital as first filed |
|---|---|---|
| 2026-06-30 | $30.50M 10-Q · filed 2026-08-17 | |
| 2026-03-31 | $25.91M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $25.45M 10-Q · filed 2026-08-17 | |
| 2025-09-30 | $25.20M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $24.04M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $23.91M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $23.74M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $21.83M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $20.61M 10-Q · filed 2024-08-19 | |
| 2024-03-31 | $20.35M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $19.41M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $19.31M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $19.24M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $19.21M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $19.19M 10-K · filed 2024-04-10 | |
| 2022-09-30 | $19.12M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $19.02M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $18.95M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $18.89M 10-K · filed 2023-03-28 | |
| 2021-09-30 | $5.55M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $4.20M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $4.10M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $2.57M 10-K · filed 2022-03-21 | $2.47M 10-K · filed 2021-03-31 |
| 2020-09-30 | $2.11M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $1.64M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $1.23M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $561.00K 10-K · filed 2021-03-31 | |
| 2019-09-30 | $106.00K 10-Q · filed 2020-01-28 | |
| 2019-06-30 | -$64.00K 10-Q · filed 2019-09-09 | |
| 2018-12-31 | $0.00 10-K/A · filed 2020-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |